Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT02723396Completed

Sleep, Awake & Move - Part I

Role: lead

NCT03681327Not ApplicableCompleted

Sleep Infra-slow Oscillations III

Role: lead

NCT05503212Completed

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions

Role: collaborator

NCT02559739Completed

Sleep Deficiency and Stroke Outcome

Role: collaborator

NCT04539431Unknown

Glioma Brain Tumours - E12513 - SensiScreen Glioma

Role: collaborator

NCT03282760Phase 1Completed

Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients

Role: collaborator

NCT03969602Not ApplicableUnknown

Cognitive Behavioral Therapy (CBT) After Lumbar Spinal Fusion in Patients With High Pain Catastrophizing

Role: lead

NCT02710487Not ApplicableCompleted

Sleep, Awake & Move - Part II

Role: lead

All 8 trials loaded